Since CD8+ CTLs were long known to function in cancer immunesurveillance [30], the observed inhibition of CD8+ T cell infiltration by IL-17 is consistent with IL-17’s role in promoting early stage CRC development [1]. The gene discussed is IL17A; the disease is colorectal carcinoma.